EUVIMEDEUVIMED entdecken
Crossref

Positive Patch Test Reaction to Sodium Metabisulfite: Prevalence, Relevance and Clinical Implications

Gabriele Casciola iD, Luca Stingeni iD, Leonardo Bianchi iD, Daniela Agostinelli iD, Marta Tramontana iD, Katharina Hansel iD

Contact Dermatitis · 2026

DOI: 10.1111/cod.70050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contact Dermatitis, 2026. Verfasst von Gabriele Casciola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy. Hauptthemen laut MEDLINE: Sulfites, Patch Tests, Dermatitis, Allergic Contact, Preservatives, Pharmaceutical. Die Arbeit nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sodium metabisulfite (SMB) is widely used as a preservative in topical products, injectable drugs, and food. Contact allergy to SMB is increasing but the relevance of SMB positive patch test reactions and clinical implications of SMB systemic exposure remain challenging.

Objectives

To assess the prevalence and relevance of SMB positive patch test reactions and to evaluate the tolerability of a local anaesthetic solution containing SMB.

Methods

A retrospective study on consecutive patch tested patients with the Italian baseline series containing SMB was performed (January 2024–April 2025). In patients who tested positive for SMB, an intradermal test with SMB and a challenge with a local anaesthetic solution containing SMB were performed.

Results

Among 550 patients consecutively patch tested with the Italian baseline series, 16 tested positive for SMB (2.9% [1.8%–4.7%]). The 16 positive reactions to SMB were not considered relevant. MOAHLFA index showed a significant positive association with Age > 40 (9.67 [1.249–74.89], p = 0.03). In all 16 patients, intradermal test with SMB and local anaesthetic challenge was negative.

Conclusions

A high prevalence of positive patch test reactions to SMB in the absence of relevance was observed. Moreover, a positive patch test to SMB seems not to contraindicate the administration of a local anaesthetic containing SMB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfitesPatch TestsDermatitis, Allergic ContactPreservatives, PharmaceuticalHumansRetrospective StudiesFemaleMaleAdultPrevalenceMiddle AgedItalyAgedAnesthetics, Local

Stichwörter der Autor:innen

contact allergylocal anaesthetic solutionprevalencerelevancesodium metabisulfitesystemic reactions

Substanzen

sodium metabisulfiteSulfitesPreservatives, PharmaceuticalAnesthetics, Local

Autor:innen und Institutionen

  • Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

ORCID-Profile: Gabriele Casciola, Luca Stingeni, Leonardo Bianchi, Daniela Agostinelli, Marta Tramontana, Katharina Hansel

Zitieren

APA

Casciola, G., Stingeni, L., Bianchi, L., Agostinelli, D., Tramontana, M., & Hansel, K. (2026). Positive Patch Test Reaction to Sodium Metabisulfite: Prevalence, Relevance and Clinical Implications. Contact Dermatitis. https://doi.org/10.1111/cod.70050

Vancouver

Casciola G, Stingeni L, Bianchi L, Agostinelli D, Tramontana M, Hansel K. Positive Patch Test Reaction to Sodium Metabisulfite: Prevalence, Relevance and Clinical Implications. Contact Dermatitis. 2026. doi:10.1111/cod.70050

BibTeX
@article{Casciola2026,
  author = {Casciola, Gabriele and Stingeni, Luca and Bianchi, Leonardo and Agostinelli, Daniela and Tramontana, Marta and Hansel, Katharina},
  title = {Positive Patch Test Reaction to Sodium Metabisulfite: Prevalence, Relevance and Clinical Implications},
  journal = {Contact Dermatitis},
  year = {2026},
  doi = {10.1111/cod.70050}
}
Kostenlos starten →